Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05967195
Other study ID # 2023-03
Secondary ID
Status Not yet recruiting
Phase Early Phase 1
First received
Last updated
Start date June 2024
Est. completion date June 2025

Study information

Verified date March 2024
Source University of Pennsylvania
Contact Willam R Smith, MD, PhD
Phone 215-898-7366
Email wrsmith5@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 145
Est. completion date June 2025
Est. primary completion date June 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. For all participants, age = 18 years old. 2. For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC). 3. For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted. 4. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form Exclusion Criteria: 1. For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis). 2. For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution. 3. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.

Study Design


Intervention

Behavioral:
Financial Incentive and Text-Messages
Patient-participants will receive modest financial incentive for attending therapy or medication management appointments combined with text messages to encourage attendance at these appointments. Text messages will be informed by principles of behavioral economics. Maximum incentive = $50/month if all appointments attended. Incentives will be pro-rated by percentage of appointments attended. Pro-rating strategies (e.g., uniform amount per appointment, escalating [aka, 'back-loaded'], or decreasing [aka 'frontloaded'] will be sequentially changed based on acceptability and other intervention-related data gathered from participants during the trial. Clinician-participants will not receive any intervention, but will receive surveys and interviews to assess their perceptions about the optimization, acceptability, scalability, and other implementation barriers/facilitators for the intervention.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Pennsylvania Penn Innovation in Suicide Prevention for Implementation Research (INSPIRE) Center

Outcome

Type Measure Description Time frame Safety issue
Other attrition rate of attrition Change at 1 year
Other attrition rate of attrition Change at 9 months
Other attrition rate of attrition Change at 6 months
Other psychotic symptomology Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. Change at 1 year
Other psychotic symptomology Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. Change at 9 months
Other psychotic symptomology Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. Change at 6 months
Other psychotic symptomology modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. Change at 11 months
Other psychotic symptomology modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. Change at 8 months
Other psychotic symptomology modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. Change at 6 months
Other depression abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) Change at 1 year
Other depression abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) Change at 9 months
Other depression abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) Change at 6 months
Other quality of life 4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) Change at 11 months
Other quality of life 4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) Change at 8 months
Other quality of life 4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) Change at 5 months
Other recovery 5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) Change at 11 months
Other recovery 5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) Change at 8 months
Other recovery 5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) Change at 5 months
Other treatment motivation (intrinsic versus extrinsic) Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. Change at 11 months
Other treatment motivation (intrinsic versus extrinsic) Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. Change at 8 months
Other treatment motivation (intrinsic versus extrinsic) Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. Change at 5 months
Other Perceived coercion Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. Change at 11 months
Other Perceived coercion Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. Change at 8 months
Other Perceived coercion Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. Change at 5 months
Other attendance rate number of appointments attended in a given period divided by number of appointments scheduled Change over 1 year
Other attendance rate number of appointments attended in a given period divided by number of appointments scheduled Change at 9 months
Other attendance rate number of appointments attended in a given period divided by number of appointments scheduled Change at 6 months
Primary Acceptability of intervention measure (AIM) The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. Change at 11 months
Primary Acceptability of intervention measure (AIM) The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. Change at 8 months
Primary Acceptability of intervention measure (AIM) The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. Change at 5 months
Primary Feasibility of intervention measure (FIM) The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. Change at 11 months
Primary Feasibility of intervention measure (FIM) The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. Change at 8 months
Primary Feasibility of intervention measure (FIM) The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. Change at 5 months
Secondary Implementation Survey Response Implementation survey. Results will be used to optimize intervention from implementation perspective. Change at 1 year
Secondary Implementation Survey Response Implementation survey. Results will be used to optimize intervention from implementation perspective. Change at 9 months
Secondary Implementation Survey Response Implementation survey. Results will be used to optimize intervention from implementation perspective. Change at 6 months
Secondary Motivation Survey Response Motivation survey. Results will be used to optimize intervention from motivation perspective. Change at 1 year
Secondary Motivation Survey Response Motivation survey. Results will be used to optimize intervention from motivation perspective. Change at 9 months
Secondary Motivation Survey Response Motivation survey. Results will be used to optimize intervention from motivation perspective. Change at 6 months
Secondary Ethical Concern Survey Response Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. Change at 1 year
Secondary Ethical Concern Survey Response Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. Change at 9 months
Secondary Ethical Concern Survey Response Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. Change at 6 months
See also
  Status Clinical Trial Phase
Completed NCT02319746 - COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSE N/A
Completed NCT04248517 - Using mHealth to Optimize Pharmacotherapy Regimens N/A
Not yet recruiting NCT05384392 - Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode N/A
Not yet recruiting NCT04792476 - HIIT in Patients With a First-episode Psychosis N/A
Recruiting NCT02334904 - Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI N/A
Completed NCT03962348 - Clinical Interviews With Detainees With Early Psychosis N/A
Recruiting NCT04368039 - Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis N/A